809 related articles for article (PubMed ID: 16647928)
1. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life.
Jelovsek JE; Barber MD
Am J Obstet Gynecol; 2006 May; 194(5):1455-61. PubMed ID: 16647928
[TBL] [Abstract][Full Text] [Related]
2. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7).
Barber MD; Walters MD; Bump RC
Am J Obstet Gynecol; 2005 Jul; 193(1):103-13. PubMed ID: 16021067
[TBL] [Abstract][Full Text] [Related]
3. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders.
Barber MD; Kuchibhatla MN; Pieper CF; Bump RC
Am J Obstet Gynecol; 2001 Dec; 185(6):1388-95. PubMed ID: 11744914
[TBL] [Abstract][Full Text] [Related]
4. Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women undergoing vaginal surgery and pessary treatment for pelvic organ prolapse.
Barber MD; Walters MD; Cundiff GW;
Am J Obstet Gynecol; 2006 May; 194(5):1492-8. PubMed ID: 16647933
[TBL] [Abstract][Full Text] [Related]
5. Genital prolapse repair using porcine skin implant and bilateral sacrospinous fixation: midterm functional outcome and quality-of-life assessment.
Daraï E; Coutant C; Rouzier R; Ballester M; David-Montefiore E; Apfelbaum D
Urology; 2009 Feb; 73(2):245-50. PubMed ID: 19038431
[TBL] [Abstract][Full Text] [Related]
6. Impact of pessary use on prolapse symptoms, quality of life, and body image.
Patel M; Mellen C; O'Sullivan DM; LaSala CA
Am J Obstet Gynecol; 2010 May; 202(5):499.e1-4. PubMed ID: 20171608
[TBL] [Abstract][Full Text] [Related]
7. [Quality of life in women with pelvic floor dysfunction].
Segedi LM; Ilić KP; Curcić A; Visnjevac N
Vojnosanit Pregl; 2011 Nov; 68(11):940-7. PubMed ID: 22191311
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for pelvic organ prolapse repair after hysterectomy.
Dällenbach P; Kaelin-Gambirasio I; Dubuisson JB; Boulvain M
Obstet Gynecol; 2007 Sep; 110(3):625-32. PubMed ID: 17766610
[TBL] [Abstract][Full Text] [Related]
9. Expression of lysyl oxidase and transforming growth factor beta2 in women with severe pelvic organ prolapse.
Kobak W; Lu J; Hardart A; Zhang C; Stanczyk FZ; Felix JC
J Reprod Med; 2005 Nov; 50(11):827-31. PubMed ID: 16419630
[TBL] [Abstract][Full Text] [Related]
10. Functional bowel and anorectal disorders in patients with pelvic organ prolapse and incontinence.
Jelovsek JE; Barber MD; Paraiso MF; Walters MD
Am J Obstet Gynecol; 2005 Dec; 193(6):2105-11. PubMed ID: 16325624
[TBL] [Abstract][Full Text] [Related]
11. Comparison of levator ani muscle defects and function in women with and without pelvic organ prolapse.
DeLancey JO; Morgan DM; Fenner DE; Kearney R; Guire K; Miller JM; Hussain H; Umek W; Hsu Y; Ashton-Miller JA
Obstet Gynecol; 2007 Feb; 109(2 Pt 1):295-302. PubMed ID: 17267827
[TBL] [Abstract][Full Text] [Related]
12. An interviewer-administered validated female pelvic floor questionnaire for community-based research.
Baessler K; O'Neill SM; Maher CF; Battistutta D
Menopause; 2008; 15(5):973-7. PubMed ID: 18458646
[TBL] [Abstract][Full Text] [Related]
13. Rectocele repair: a randomized trial of three surgical techniques including graft augmentation.
Paraiso MF; Barber MD; Muir TW; Walters MD
Am J Obstet Gynecol; 2006 Dec; 195(6):1762-71. PubMed ID: 17132479
[TBL] [Abstract][Full Text] [Related]
14. Pelvic floor symptoms and lifestyle factors in older women.
Bradley CS; Kennedy CM; Nygaard IE
J Womens Health (Larchmt); 2005 Mar; 14(2):128-36. PubMed ID: 15775730
[TBL] [Abstract][Full Text] [Related]
15. Patient related risk factors for recurrent stress urinary incontinence surgery in women treated at a tertiary care center.
Daneshgari F; Moore C; Frinjari H; Babineau D
J Urol; 2006 Oct; 176(4 Pt 1):1493-9. PubMed ID: 16952667
[TBL] [Abstract][Full Text] [Related]
16. Fecal incontinence in women with urinary incontinence and pelvic organ prolapse.
Jackson SL; Weber AM; Hull TL; Mitchinson AR; Walters MD
Obstet Gynecol; 1997 Mar; 89(3):423-7. PubMed ID: 9052598
[TBL] [Abstract][Full Text] [Related]
17. Pelvic organ prolapse in defecatory disorders.
Klingele CJ; Bharucha AE; Fletcher JG; Gebhart JB; Riederer SG; Zinsmeister AR
Obstet Gynecol; 2005 Aug; 106(2):315-20. PubMed ID: 16055581
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle heavy-chain polypeptide 3 and myosin binding protein H in the pubococcygeus muscle in patients with and without pelvic organ prolapse.
Hundley AF; Yuan L; Visco AG
Am J Obstet Gynecol; 2006 May; 194(5):1404-10. PubMed ID: 16579921
[TBL] [Abstract][Full Text] [Related]
19. The long-term effect of raloxifene on the genitourinary tract.
Sharma S; Albertazzi P; Bottazzi M
Climacteric; 2007 Jun; 10(3):244-8. PubMed ID: 17487651
[TBL] [Abstract][Full Text] [Related]
20. Long-term quality-of-life outcome after mesh sacrocolpopexy for vaginal vault prolapse.
Thomas AZ; Giri SK; Cox AM; Creagh T
BJU Int; 2009 Dec; 104(11):1676-9. PubMed ID: 19522867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
